CRLX101 - PDFSEARCH.IO - Document Search Engine

CRLX101
Results: 6

#	Item
1	BioCentury, THE BERNSTEIN R EPORT Add to Reading List Source URL: thujacapital.com Language: English - Date: 2013-06-24 09:06:43 CRLX101 Nanoparticle Docetaxel Organic chemistry Nanotechnology Nanomaterials Chemistry
2	Award ID: DP150091 Project Title: Selective Tumor Delivery of Anti-Cancer Agents in Ovarian Cancer Therapy Award Mechanism: Bridging the Gap: Early Translational Research Awards Add to Reading List Source URL: www.cprit.state.tx.us Language: English - Date: 2014-11-20 01:49:27 Cancer treatments Ovarian cancer Cancer Chemotherapy CRLX101 Management of cancer Medicine Oncology Gynaecological cancer
3	The team at Cerulean (NASDAQ: CERU) is committed to improving treatment for people living with cancer. We apply our Dynamic Tumor Targeting™ Platform to create a portfolio of nanoparticle-drug conjugates (NDCs) designe Add to Reading List Source URL: www.ceruleanrx.com Language: English - Date: 2015-06-01 11:12:23 Docetaxel Ovarian cancer Renal cell carcinoma Metastasis Antibody-drug conjugate Cyclacel Medicine Bevacizumab CRLX101
4	Nanoparticles may exploit tumor weaknesses to selectively attack cancers Add to Reading List Source URL: phys.org Language: English - Date: 2015-05-03 15:44:22 Nanotechnology Neuroblastoma Nanoparticle Enhanced permeability and retention effect Management of cancer CRLX101 Nanomedicine Medicine Oncology Brain tumor
5	active agent needs to enter the body, travel through the bloodstream to arrive at the tumour site, penetrate the tumour mass and then gain entry to Add to Reading List Source URL: www.nature.com Language: English - Date: 2014-06-02 12:30:08 Nanomaterials Nanoparticle Nanotechnology Ultraviolet radiation CRLX101 Trastuzumab Chemotherapy Breast cancer Management of cancer Medicine Cancer treatments Ribbon symbolism
6	Targeted Delivery System of Nanobiomaterials in Anticancer Therapy: From Cells to Clinics Add to Reading List Source URL: www.ncbi.nlm.nih.gov Language: English Glycosides Myocet Liposome Targeted therapy Metastatic breast cancer Paclitaxel CRLX101 Cancer vaccine Doxorubicin Medicine Anthracyclines Oncology

UPDATE